Yuling Liu
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 16
- Bioactive natural compounds 6
- Gut microbiota and health 4
- Biomaterials 27
- Nanoparticle-Based Drug Delivery 19
- Co-authors
- Longfei Lin (25 shared papers)Lei Yan (4 shared papers)Xuejun Xia (21 shared papers)Hui Li (5 shared papers)Hui Li (14 shared papers)Jian Ni (6 shared papers)Yanfang Yang (17 shared papers)Cuiping Zhou (4 shared papers)
- Journals
- International Journal of Nanomedicine (9 papers)Molecules (6 papers)Journal of Ethnopharmacology (4 papers)RSC Advances (3 papers)Investigative Ophthalmology & Visual Science (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Yuling Liu
108 papers receiving 2.8k citations
Yuling Liu's Hit Papers
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 419
- Biomaterials 488
- Toxicology 66
- Molecular Medicine 89
- Molecular Biology 998
Countries citing papers authored by Yuling Liu
This map shows the geographic impact of Yuling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Liu more than expected).
Fields of papers citing papers by Yuling Liu
This network shows the impact of papers produced by Yuling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Liu. The network helps show where Yuling Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019 Hit paper breakdown → | 2021 | 242 |
| 2 | 2019 | 145 | |
| 3 | 2020 | 118 | |
| 4 | 2010 | 118 | |
| 5 | 2020 | 105 | |
| 6 | 2020 | 99 | |
| 7 | 2016 | 98 | |
| 8 | 2011 | 83 | |
| 9 | 2017 | 72 | |
| 10 | 2019 | 72 | |
| 11 | 2019 | 67 | |
| 12 | 2017 | 67 | |
| 13 | 2019 | 64 | |
| 14 | 2020 | 58 | |
| 15 | 2019 | 56 | |
| 16 | 2021 | 55 | |
| 17 | 2017 | 50 | |
| 18 | 2016 | 50 | |
| 19 | 2020 | 47 | |
| 20 | 2014 | 45 |
About Yuling Liu
Yuling Liu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Pharmaceutical Science and Organic Chemistry, having authored 112 papers that have together received 2.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (16 papers), Advancements in Transdermal Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced Drug Delivery Systems (10 papers), Pharmacological Effects of Natural Compounds (6 papers), Bioactive natural compounds (6 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Pharmaceutical Science (419 citations), Biomaterials (488 citations), Toxicology (66 citations), Molecular Medicine (89 citations) and Molecular Biology (998 citations). Yuling Liu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Longfei Lin, Lei Yan, Xuejun Xia, Hui Li, Hui Li, Jian Ni, Yanfang Yang, Cuiping Zhou, Hongliang Wang and Hongjun Yang. Their work appears in journals such as International Journal of Nanomedicine, Molecules, Journal of Ethnopharmacology, RSC Advances and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.